On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

Kennedy Jr., Trump's pick for HHS secretary. However, it remains unclear how much could actually change if Kennedy were to be ...

FDA faces radical changes under Trump, risking public health and regulatory stability. • Trump reinstates the “Schedule F” order, threatening federal employees’ job security and increasing political ...

NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.